Next Article in Journal

Inclusion Scenarios and Conformational Flexibility of the SSRI Paroxetine as Perceived from Polymorphism of β-Cyclodextrin–Paroxetine Complex

Previous Article in Journal

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching

You seem to have javascript disabled. Please note that many of the page functionalities won't work as expected without javascript enabled.

Search for Articles:

Title / Keyword

Author / Affiliation / Email

Journal

Article Type

Advanced Search

Section

Special Issue

Volume

Issue

Number

Page

Logical OperatorOperator

Search Text

Search Type

Submit to this Journal Review for this Journal Propose a Special Issue

Article Menu

Share Help Cite Discuss in SciProfiles

Open AccessSystematic Review

Article Versions Notes

Pharmaceuticals 2022, 15(1), 100; https://doi.org/10.3390/ph15010100

Action	Date	Notes	Link
article xml file uploaded	14 January 2022 14:06 CET	Original file	-
article xml uploaded.	14 January 2022 14:06 CET	Update	https://www.mdpi.com/1424-8247/15/1/100/xml
article pdf uploaded.	14 January 2022 14:06 CET	Version of Record	https://www.mdpi.com/1424-8247/15/1/100/pdf
article supplementary file uploaded.	14 January 2022 14:06 CET	-	https://www.mdpi.com/1424-8247/15/1/100#supplementary
article html file updated	14 January 2022 14:08 CET	Original file	-
article html file updated	31 July 2022 03:52 CEST	Update	https://www.mdpi.com/1424-8247/15/1/100/html

Back to TopTop